Green dye to improve recovery after prostate cancer surgery
Treatments studied
Part of Cancer, Kidney & urinary clinical trials.
This trial tests whether using a green dye (ICG) during robot-assisted prostate removal helps preserve urinary and sexual function. It is for men with localized prostate cancer and good baseline erectile function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a man 18 years or older with prostate cancer that has not spread outside the prostate.
- Have a recent erectile function score (SHIM) of 10 or higher.
- Be a good candidate for nerve-sparing surgery, as decided by your surgeon.
- Not have used injections or a penile implant for erectile dysfunction (oral pills are fine).
- Not have had prior prostate cancer treatments like hormone therapy, radiation, or focal therapy.
- Not be allergic to iodine, ICG dye, or shellfish.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a dye that makes prostate cancer cells glow during robot-assisted surgery. The goal is to help surgeons remove all the cancer while protecting healthy tissue.
This trial tests if a green dye helps surgeons see and remove lymph nodes more clearly during 3D laparoscopic stomach cancer surgery. The goal is to confirm the dye's safety and benefit for patients undergoing this procedure.
This trial tests whether a green dye called indocyanine green can help surgeons find and remove more lymph nodes during laparoscopic surgery for advanced stomach cancer. It may improve the chances of removing all cancer.
This trial tests a program to help men recover erectile function after prostate cancer treatment. It is for men with a specific type of prostate cancer that hasn't spread and who still have some erectile function.
This trial uses a special dye called ICG that makes cancer glow under a special camera during breast cancer surgery. Doctors want to find the best time to give the dye so they can see the cancer clearly and remove all of it in one operation.
This trial tests whether a special green dye (indocyanine green) injected during minimally invasive stomach cancer surgery helps doctors remove more lymph nodes, which may improve treatment. It is for people with stomach adenocarcinoma that has not spread to distant organs.
Hear when a new Prostate Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.